<DOC>
	<DOCNO>NCT01808690</DOCNO>
	<brief_summary>Diabetes increasingly common among youth , forecast early complication . Type 1 ( T1D ) cause early heart disease , shorten lifespan despite modern improvement control blood sugar risk factor heart disease . Poor insulin action , otherwise know insulin resistance ( IR ) , main factor cause heart disease type 2 diabetes ( T2D ) , cause increase heart disease T1D unclear . IR may contribute heart disease T1D T2D , investigator others find presence IR T1D . Much less known IR T1D , well understanding role T1D critical understanding cause heart disease T1D . The investigator long-term goal understand early cause heart disease diabetes prevent . The investigator unique initial finding suggest even reasonably well-controlled , normal weight , T1D youth IR . The IR appear directly related heart , blood vessel , exercise defect , pattern appear different T2D . The goal study determine unique heart , blood vessel insulin sensitivity abnormality T1D youth , determine whether metformin improve abnormality . A clear understanding factor help determine cause , treatment could help abnormality . Hypothesis 1 : Metformin improve insulin function mitochondrial function T1D . Hypothesis 2 : Metformin improve vascular cardiac function T1D . All measure perform twice , 3-month randomize , placebo-controlled design subject randomize either metformin placebo . The independent impact insulin action well glucose level , BMI , T1D duration , gender baseline outcomes impact change insulin action , glucose level BMI response metformin also examine help customize future strategy prevent heart disease T1D . This study advance field provide new information role poor insulin action heart disease T1D , whether improve insulin action T1D helpful . If focus directly improve insulin action T1D youth support study , clinical approach T1D management may significantly change .</brief_summary>
	<brief_title>EMERALD : Effects Metformin Cardiovascular Function Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Adolescents 1219 year age type 1 diabetes ( define positive antibody well insulin requirement ) 2 . Sedentary nature ( &lt; 3 hour physical activity/week ) 3 . Willing consent participation study 4 . Body Mass Index ( BMI ) &gt; 5 % growth chart 1 . Current use medication know affect insulin sensitivity : oral glucocorticoid within 10 day , atypical antipsychotic , immunosuppressant agent , metformin thiazolidinediones . 2 . Currently pregnant breastfeed woman 3 . Use thiazolidinedione within 12 week 4 . Severe illness Diabetic Ketoacidosis within 60 day 5 . Macroalbuminuria 6 . Hemoglobin A1c &gt; 12 % 7 . Weight &gt; 136.4 kg &lt; 42 kg , BMI &lt; 5 % 8 . Creatinine &gt; 1.2 9 . Hemoglobin &lt; 9 10 . Major psychiatric developmental disorder limit informed consent 11 . Implanted metal device 12 . Inability tolerate â‰¥500mg twice day metformin</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Adolescent</keyword>
	<keyword>Youth</keyword>
	<keyword>Diabetes</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Cardiovascular</keyword>
	<keyword>Metformin</keyword>
</DOC>